Quantitative proteomics analysis reveals possible anticancer mechanisms of 5’-deoxy-5’-methylthioadenosine in cholangiocarcinoma cells
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0306060 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Kankamol Kerdkumthong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science, Division of Health and Applied Sciences, Biochemistry Graduate Program, Prince of Songkla University, Hatyai, Songkhla, Thailand. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Proteomics, Deoxyadenosines, Bile Duct Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Science, Research and Innovation Fund (NSRF) and Prince of Songkla University, a Prince of Songkla University-Ph.D. Scholarship.
Abstract (Originalsprache)
Cholangiocarcinoma (CCA) is an aggressive cancer originating from bile duct epithelium, particularly prevalent in Asian countries with liver fluke infections. Current chemotherapy for CCA often fails due to drug resistance, necessitating novel anticancer agents. This study investigates the potential of 5’-deoxy-5’-methylthioadenosine (MTA), a naturally occurring nucleoside, against CCA. While MTA has shown promise against various cancers, its effects on CCA remain unexplored. We evaluated MTA’s anticancer activity in CCA cell lines and drug-resistant sub-lines, assessing cell viability, migration, invasion, and apoptosis. The potential anticancer mechanisms of MTA were explored through proteomic analysis using LC-MS/MS and bioinformatic analysis. The results show a dose-dependent reduction in CCA cell viability, with enhanced effects on cancer cells compared to normal cells. Moreover, MTA inhibits growth, induces apoptosis, and suppresses cell migration and invasion. Additionally, MTA enhanced the anticancer effects of gemcitabine on drug-resistant CCA cells. Proteomics revealed the down-regulation of multiple proteins by MTA, affecting various molecular functions, biological processes, and cellular components. Network analysis highlighted MTA’s role in inhibiting proteins related to mitochondrial function and energy derivation, crucial for cell growth and survival. Additionally, MTA suppressed proteins involved in cell morphology and cytoskeleton organization, important for cancer cell motility and metastasis. Six candidate genes, including ZNF860, KLC1, GRAMD1C, MAMSTR, TANC1, and TTC13, were selected from the top 10 most down-regulated proteins identified in the proteomics results and were subsequently verified through RT-qPCR. Further, KLC1 protein suppression by MTA treatment was confirmed through Western blotting. Additionally, based on TCGA data, KLC1 mRNA was found to be upregulated in the tissue of CCA patients compared to that of normal adjacent tissues. In summary, MTA shows promising anticancer potential against CCA by inhibiting growth, inducing apoptosis, and suppressing migration and invasion, while enhancing gemcitabine’s effects. Proteomic analysis elucidates possible molecular mechanisms underlying MTA’s anticancer activity, laying the groundwork for future research and development of MTA as a treatment for advanced CCA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Science, Division of Health and Applied Sciences, Biochemistry Graduate Program, Prince of Songkla University, Hatyai, Songkhla, Thailand.
- Faculty of Pharmaceutical Sciences, Department of Pharmacognosy and Pharmaceutical Botany, Prince of Songkla University, Hatyai, Songkhla, Thailand.
- National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathumtani, Thailand.
- Faculty of Science, Center of Excellence for Biochemistry, Prince of Songkla University, Hatyai, Songkhla, Thailand.
ORCID-Profile: Sutthipong Nanarong, Sittiruk Roytrakul, Phanthipha Runsaeng, Sumalee Obchoei
Förderung
- the National Science, Research and Innovation Fund (NSRF) and Prince of Songkla University
- a Prince of Songkla University-Ph.D. Scholarship
Zitieren
APA
Kerdkumthong, K., Nanarong, S., Roytrakul, S., Pitakpornpreecha, T., Tantimetta, P., Runsaeng, P., & Obchoei, S. (2024). Quantitative proteomics analysis reveals possible anticancer mechanisms of 5’-deoxy-5’-methylthioadenosine in cholangiocarcinoma cells. PLOS ONE. https://doi.org/10.1371/journal.pone.0306060
Vancouver
Kerdkumthong K, Nanarong S, Roytrakul S, Pitakpornpreecha T, Tantimetta P, Runsaeng P, et al. Quantitative proteomics analysis reveals possible anticancer mechanisms of 5’-deoxy-5’-methylthioadenosine in cholangiocarcinoma cells. PLOS ONE. 2024. doi:10.1371/journal.pone.0306060
BibTeX
@article{Kerdkumthong2024,
author = {Kerdkumthong, Kankamol and Nanarong, Sutthipong and Roytrakul, Sittiruk and Pitakpornpreecha, Thanawat and Tantimetta, Phonprapavee and Runsaeng, Phanthipha and Obchoei, Sumalee},
title = {Quantitative proteomics analysis reveals possible anticancer mechanisms of 5’-deoxy-5’-methylthioadenosine in cholangiocarcinoma cells},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0306060}
}
EUVIMED